HIC2 anticorps (Internal Region)
-
- Antigène Voir toutes HIC2 Anticorps
- HIC2 (Hypermethylated in Cancer 2 (HIC2))
-
Épitope
- AA 188-200, Internal Region
-
Reactivité
- Humain, Souris, Rat, Chien, Boeuf (Vache), Porc
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp HIC2 est non-conjugé
-
Application
- Western Blotting (WB)
- Réactivité croisée (Details)
-
Species reactivity (expected):Mouse, Rat, Canine (Dog), Pig, Bovine.
Species reactivity (tested):Human. - Purification
- Affinity Chromatography
- Immunogène
- Synthetic peptide from the internal region of Human HIC2 (NP_055909.2). Genename: HIC2
- Top Product
- Discover our top product HIC2 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Concentration
- 0.5 mg/mL
- Buffer
- Tris saline, pH ~7.3nizes, 0.02 % Sodium Azide, 0.5 % BSA
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freezing and thawing.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Antigène
- HIC2 (Hypermethylated in Cancer 2 (HIC2))
- Autre désignation
- HIC2 / ZBTB30 (HIC2 Produits)
- Synonymes
- anticorps HIC2, anticorps hic2, anticorps MGC154932, anticorps HRG22, anticorps ZBTB30, anticorps ZNF907, anticorps AA409108, anticorps mKIAA1020, anticorps zgc:109776, anticorps HIC ZBTB transcriptional repressor 2, anticorps hypermethylated in cancer 2 L homeolog, anticorps hypermethylated in cancer 2, anticorps HIC2, anticorps hic2.L, anticorps Hic2, anticorps hic2
- Sujet
- Synonyms: HIC-2, HIC-3, HIC1-related gene on chromosome 22, HIC3, HRG22, Hypermethylated in cancer 2 protein, KIAA1020, Zinc finger and BTB domain-containing protein 30
- Poids moléculaire
- 66.2 kDa (NP_055909.2)
- ID gène
- 23119
- NCBI Accession
- NP_055909
-